Does WARFARIN Cause Product solubility abnormal? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product solubility abnormal have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.0% of all adverse event reports for WARFARIN.
8
Reports of Product solubility abnormal with WARFARIN
0.0%
of all WARFARIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product solubility abnormal From WARFARIN?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
NITROGLYCERIN (81)